Implandata Opthalmic, based in Hannover, Germany, is a company dedicated to the development of an intraocular pressure measurement system. The company produces an implantable sensor that can reduce the number of glaucoma patients to see a doctor. Once installed in the patient, the pressure sensor can send wireless data to the doctor's database and provide an outsider version of the patient data application. 
Glaucoma is known to have mild symptoms and the patient's vision is constantly shrinking. It is usually too late to be treated. This makes early monitoring an attractive method. Patients can master their own eye status, which will change glaucoma management.
Previous studies have provided the basis for a microimplanted wireless IOP measuring device, although the original intention of this design was to target cataract patients for cataract surgical implantation. For those who are not cataracts, the implant procedure is roughly similar to laser-corrected Lasik surgery. The company's ongoing clinical trials have received CE certification in Europe, and the medical equipment required for implantation has begun to be sold in Europe.